Home
About AASHP
Officers
Newsletters
Meetings
Photos
Links
Membership
Contact Us

 

Tuesday, November 9, 2010  
AASHP/CAPA Joint Dinner Meeting

Date Tuesday, November 9, 2010
Time  
6:30-7:00   Social ½ Hour, registration and buffet meal
7:00-8:00   Program
8:00-8:30   AASHP and CAPA Business Meetings

Place   North Austin Medical Center Auditorium
2nd Floor
12221 Mopac
Austin TX 78758
phone: 512-901-1000

Website: http://stdavids.com/sdnamc.aspx
Click for a map.


Topic and Speaker "Safe and Effective Use of Insulin Therapy Through the Continuum of Hospital Care"

Curtis L. Triplett, PharmD, BCPS, CDE 

The Universal Activity Numbers (UAN)
0297-9999-10-003-L01-P
1 contact hours (0.1 CEUs)

OVERVIEW: The prevalence of diabetes in hospitalized adults is conservatively estimated at 12%-25%, depending on the thoroughness used to identify patients. In one study conducted at a community teaching hospital, the prevalence of inpatient hyperglycemia was 38%; one-third of these patients were identified as having newly discovered hyperglycemia. Recent data show that there were almost 6 million hospitalizations with diabetes as a listed diagnosis. Nationally, a third of adults with diabetes are unaware of their condition, which may not be recognized until a patient is hospitalized for some aspect of diabetes complications. Hyperglycemia in the hospital may result from several causes: stress or diabetes decompensation, and/or may be iatrogenic. The economic burden of diabetes in the US in 2007 was estimated to be $174 billion, of which hospitalization was the major component (50% of the total). Hyperglycemia in the hospital setting, whether in critically ill patients or those not critically ill, is associated with worse outcomes, both in patients with a previous diagnosis of diabetes and in those with newly recognized glucose abnormalities. Inpatient hyperglycemia also is associated with longer lengths of stay.

LEARNING OBJECTIVES: After completing this CE activity, participants should be able to:
• Establish or revise glycemic targets in line with the current evidence base
• Create medication order practices to support the safe and effective use of insulin therapy
• Implement practices to reduce the risk of insulin-related medication errors
 
Sponsors   This activity is jointly sponsored by the American Academy of CME and E&S MedEd Group. It is being supported by an educational grant from Novo Nordisk Inc.

RSVP   The meal is free for all members of AASHP or CAPA. 
Non-members may join AASHP at the door.
Dues are $35 for pharmacists;
$20 for pharmacy technicians;
 and $15 for students.

If you are not a member, and feel that that you
cannot afford the program but would like to attend,
please contact .

This meeting is closed.  If you hold a confirmed reservation and cannot attend, be sure to email <cancel@aashp.net> so we can remove you from the list.

Seating is limited.
RSVPs will be accepted through
Wednesday, November 3, 2010


Target audience: This activity has been designed to meet the educational needs of endocrinologists, hospitalists, inpatient pharmacists, nurses, and certified diabetes educators involved in the management of hospitalized patients with hyperglycemia.

American Academy of CME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Each module provides 1.0 contact hours (0.1 CEUs) of continuing education credit.  In order for participants to receive their CME/CE certificate or Statement of Credit, they must sign-in, participate in an activity module, and return a completed evaluation form. A CME/CE certificate or Statement of Credit will be mailed within 6–8 weeks.


 
 
 

Copyright 2013 Austin Area Society of Health-System Pharmacists
PO Box 92341 • Austin, Texas 78709-2341

Questions about this site? Email the